Drug Trial Radar · NCT00812461
Efficacy of Nalmefene in Patients With Alcohol Dependence
Last checked: Nov 20, 2026Latest source record: Jul 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
678
Actual
Start
Mar 2009
Primary completion
Mar 2011
Study completion Apr 2011
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Dec 22, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy, safety and tolerability of nalmefene in the treatment of alcohol dependence.
Conditions
- Alcohol Dependence
Interventions
PlaceboDrug
as-needed use, tablets, orally, 6 months
NalmefeneDrug
18.06 mg, as-needed use, tablets, orally, 6 months. 18.06 mg nalmefene equals 20 mg nalmefene hydrochloride.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Monthly Number of Heavy Drinking Days (HDDs)Time frame: Baseline and Month 6
- Change From Baseline in the Monthly Total Alcohol Consumption (TAC)Time frame: Baseline and Month 6
Locations
57 sites in 7 countries. Site status is shown where the registry gives one.
BE002
Assebroek, Belgium
BE007
Bruges, Belgium
BE006
Charleroi, Belgium
BE005
Kortenberg, Belgium
BE001
Liège, Belgium
BE003
Mechelen, Belgium
BE004
Ostend, Belgium
CZ001
Litoměřice, Czechia
CZ002
Prague, Czechia
CZ003
Prague, Czechia
FR008
Angers, France
FR004
Bully-les-Mines, France
FR009
Clichy, France
FR012
Élancourt, France
FR021
La Rochelle, France
FR011
Le Pecq, France
FR019
Lille, France
FR016
Lyon, France
FR014
Nancy, France
FR015
Nîmes, France
FR002
Rennes, France
FR001
Sartrouville, France
FR007
Strasbourg, France
FR005
Toulouse, France
FR006
Toulouse, France
FR003
Villejuif, France
IT017
Bologna, Italy
IT013
Bologna, Italy
IT008
Cento, Italy
IT006
Florence, Italy
IT002
Parma, Italy
IT007
Rome, Italy
IT001
Rome, Italy
IT011
Rome, Italy
IT004
Rome, Italy
IT018
Soverato Marina, Italy
PL005
Gdansk, Poland
PL004
Leszno, Poland
PL006
Lublin, Poland
PL007
Lublin, Poland
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.